Home » Topics » BioWorld Science

BioWorld Science
RSS

Magmas inhibition as new therapeutic strategy in medulloblastoma

June 20, 2022

CD47 blockade with 225Ac-anti-CD33 radioimmunoconjugate in acute myeloid leukemia

June 20, 2022

Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates

June 20, 2022

Cytokine promotes heart repair after infarct

June 20, 2022

PIK3C2B variants impact mTOR pathway and lead to lipid signaling-driven focal epilepsy

June 20, 2022

Combinatorial analytics identifies hundreds of precise drug repositioning opportunities

June 17, 2022

TULP3 mutations cause degeneration of major organs

June 17, 2022

Gossamer Bio presents Janus kinase inhibitors

June 17, 2022

Enanta Pharmaceuticals identifies new SARS-CoV-2 3C-like proteinase inhibitors

June 17, 2022

Vertex Pharmaceuticals discloses new CFTR modulators

June 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...